Kraig Biocraft Laboratories Inc (KBLB)

[arachnodude]

Actualities and realities in 2019...

- The promise for their 1st commercial production failed. OPINION.

- The NASDAQ uplist hasn't happened. In Process

- The Board Elect hasn't been seated. Company has issued a standing statement which says they will be seated prior to uplist.

- Nothing has happened with Prodigy. I guess if one doesn't include...obtaining approvals to commence rearing operations in Vietnam, completing the buildout of the factory in Vietnam, the initial scale up of overseas production operations, advancements in R&D and IP portfolio, strengthening corporate governance in preparations for bigger things, and growth of market cap by more than 285%.

- KBLB took out a $300K note with Notre Dame, which hasn't been paid back. The Company settled $243,159 of accounts payable to the University of Notre Dame.

- The promised documentary never happened. It was a pinky-swear promise.

- They submitted (5) provisional patents, most (if not all) of which have expired. Most (4/5) are still active. (2) in published status and (2) in pending status.

- Dr. Kane was promoted, and is now gone. Was his contract for indefinite employment?

- They promised annual shareholders meetings, but not one has taken place since. There was only one that could have taken place since and it was interrupted by a Global Pandemic and an ongoing Uplist process.

And let's not forget the company's share price achieved it's ATH in 2019.

Signs of a successful company moving forward towards sustainability. Can't wait to see what the rest of this success story reads like.